MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera
Clinical trial NCT04116502 · RECRUITING
Trial details
- NCT number
- NCT04116502
- Sponsor
- University of Birmingham
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-25
- Primary completion
- 2028-10-31
- Enrollment
- 586
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.